Nordson Total Cost of Revenue increased by 11.0% to $336.77M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 9.0%, from $309.03M to $336.77M. Over 4 years (FY 2021 to FY 2025), Total Cost of Revenue shows an upward trend with a 4.8% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase relative to revenue suggests rising production costs or margin compression, while a decrease suggests improved operational efficiency.
Total cost of revenue includes the direct costs attributable to the production of goods or the delivery of services sold...
Varies by industry; for medical device manufacturers, this includes significant manufacturing and supply chain costs.
total_cost_of_revenue| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $251.84M | $281.59M | $268.10M | $269.03M | $277.77M | $296.54M | $320.40M | $281.61M | $298.04M | $288.36M | $335.22M | $284.77M | $284.77M | $292.60M | $341.66M | $279.52M | $309.03M | $334.99M | $328.35M | $303.34M | $336.77M |
| QoQ Change | — | +11.8% | -4.8% | +0.3% | +3.2% | +6.8% | +8.0% | -12.1% | +5.8% | -3.2% | +16.3% | -15.1% | -0.0% | +2.8% | +16.8% | -18.2% | +10.6% | +8.4% | -2.0% | -7.6% | +11.0% |
| YoY Change | — | — | — | — | +10.3% | +5.3% | +19.5% | +4.7% | +7.3% | -2.8% | +4.6% | +1.1% | -4.5% | +1.5% | +1.9% | -1.8% | +8.5% | +14.5% | -3.9% | +8.5% | +9.0% |